[Retracted] Effect of Hematocrit Injury on the Survival Rate of Advanced Malignant Tumors and Its Clinical Significance

Table 2

Univariate analysis of factors affecting survival of patients with advanced malignant tumor.

Factors		Percentage (%)	Average survival days	Median survival days
KPS					<0.05
<30	38	31.67	17 (13~21)	8 (6~10)
≥30	82	68.33	29 (25~32)	20 (16~24)
Dyspnea	0				<0.05
Yes	36	30.00	20 (14~25)	9 (7~11)
No	84	70.00	27 (23~30)	19 (15~23)
Delirium	0				<0.05
Yes	25	20.83	11 (7~15)	6 (4~8)
No	111	92.50	28 (24~32)	21 (17~25)
Red blood cell storage time (d)	0				<0.05
>14	51	42.50	20 (16~24)	18 (13~23)
≤14	69	57.50	29 (24~33)	13 (7~19)
Lym (%)	0				<0.05
≤12	78	65.00	22 (18~26)	13 (7~19)
>12	42	35.00	30 (24~35)	25 (18~32)
LDH (U/L)	0				<0.05
>500	50	41.67	17 (14~21)	9 (6~12)
≤500	70	58.33	30 (25~34)	22 (17~27)
ALB(g/L)	0				<0.05
<30	70	58.33	20 (16~24)	11 (7~15)
≥30	50	41.67	31 (26~36)	26 (19~33)